Automated Antimicrobial Susceptibility Testing Market To Raise Significant Opportunities As SpeeDx Receives Funding From CARB-X To Diagnose Antimicrobial Susceptibility



The Antimicrobial Susceptibility Test (AST) is a computerized diagnostic test to detect antimicrobial resistant strains of bacteria, fungi and viruses. It is intended for the rapid diagnosis and rapid treatment of a wide range of conditions, from staph infections to food poisoning. The test is usually done on people who may be carriers of a high or low level of a particular microorganism that has recently been identified as the cause of an outbreak of a specific disease. Candida, as the bacteria responsible for infections caused by candida, cannot be detected by any other means. Infectious diseases such as gonorrhea, Aspergillus fumigatus, cholera, Escherichia meningitides and Streptococcus pneumonia are causing a growing number of epidemics and are poised to drive the expansion of the automated antimicrobial susceptibility market. . In May 2021, an advanced diagnostic services company, SpeeDx, confirmed that it had secured approximately US $ 1.8 million in funding from CARB-X, a leading company focused on antibacterial R&D activities, to perform testing. antimicrobial susceptibility test (AST) to determine gonorrhea and chlamydia infection.

For detailed information, get a free PDF copy of this report @

To note: * PDF only includes Table of Contents (ToC), actual report search frame, and search methodology.

Geographically, the North America region bodes well with the market for automated antimicrobial susceptibility testing amid the growing number of infectious diseases, safety risks and technical advancements in antimicrobial resistance products all spur R&D to create new automated AST systems. Likewise, the market for automated antimicrobial susceptibility testing is experiencing stagnant growth in the Asia-Pacific region due to increased awareness among healthcare providers of the importance of antimicrobial susceptibility testing in the treatment of bacterial infections. .

In May 2021, the World Health Organization (WHO) ranked AMR (antimicrobial resistance) among the top ten public health risks facing humanity. Increased incidence of infections caused by bacterial pathogens and microbial overuse, which contributes to antibiotic resistance of bacterial organisms; the emergence of improved guidelines for fungal susceptibility; and the use of rapid commercial AST systems for fungal research all broaden the scope of the automated antimicrobial susceptibility testing market. However, the abuse and overuse of antimicrobials associated with high-priced AST instruments restricts the scope of the automated antimicrobial susceptibility testing market.

Major Players Include Automated Antimicrobial Susceptibility Testing Market РbioM̩rieux SA, HiMedia Laboratories, Alifax Holding SpA, Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA and Bio-Rad Laboratories, Inc.

The testing process consists of two steps: the pre-antibiotic resistance test (RST) and the post-antibiotic resistance test (RAT). First, a sample of culture material is obtained and mixed with glucose, saline, or other deionized buffer. After mixing, a sample of the microorganism is then added to the buffer. Then, a highly sensitive optical cell is used to identify and count the number of antigens or microorganisms bound to the surface of the sample. The total number of antigens detected by the optical cell is called the cutoff concentration or CFU / ml.


To get instant access, purchase the report here with a flat rate discount of US $ 2000 @ –

Contact us

Mr. Shah
Consistent market information
1001 4th avenue, # 3200
Seattle, Washington 98154
Phone: United States +12067016702 / United Kingdom +4402081334027
Email: [email protected]


Leave A Reply

Your email address will not be published.